TITLE

CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer

AUTHOR(S)
Ogino, Shuji; Nosho, Katsuhiko; Kirkner, Gregory J.; Kawasaki, Takako; Meyerhardt, Jeffrey A.; Loda, Massimo; Giovannucci, Edward L.; Fuchs, Charles S.
PUB. DATE
January 2009
SOURCE
Gut;Jan2009, Vol. 58 Issue 1, p90
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: The CpG island methylator phenotype (CIMP) characterised by widespread promoter methylation, is associated with microsatellite instability )MSI) and BRAF mutation in colorectal cancer. The independent effect of CIMP, MSI and BRAF mutation on prognosis remains uncertain. Methods: Utilising 649 colon cancers (stage I-IV) in two independent cohort studies, we quantified DNA methy- lation in eight CIMP-specific promoters (CACNA1G, CDKN2A (p16), CRABPI, /GF2, MLH1, NEUROG1, RUNX3 and SOCS1) as well as CHFR, H/Cl, /GFBP3, MGMT, MINT1, MINT31, p14, and WRN by using MethyLight technology. We examined MSI, KRAS and BRAF status. Cox proportional hazard models computed hazard ratios (HRs) for colon cancer-specific and overall mortalities, adjusting for patient characteristics and tumoral molecular features. Results: After adjustment for other predictors of patient survival, patients with CIMP-high cancers (126 (19%) tumours with ⩾6/8 methylated CIMP-specific promoters) experienced a significantly low colon cancer-specific mortality (multivariate HR 0.44, 95% confidence interval (Cl) 0.22 to 0.88), whereas the BRAF mutation was significantly associated with a high cancer-specific mortality (multivariate HR 1.97, 95% Cl 1.13 to 3.42). A trend toward a low cancer-specific mortality was observed for MSI-high tumours (multivariate HR 0.70, 95% Cl 0.36 to 1.37). In stratified analyses, CIMP-high tumours were associated with a significant reduction in colon cancer-specific mortality, regardless of both MSI and BRAF status. The relation between CIMP-high and lower mortality appeared to be consistent across all stages. KRAS mutation was unrelated to prognostic significance. Conclusion: CIMP-high appears to be an independent predictor of a low colon cancer-specific mortality, while BRAF mutation is associated with a high colon cancer- specific mortality.
ACCESSION #
35965713

 

Related Articles

  • Clinical Guidelines Versus Universal Molecular Testing: Are We Ready to Choose an Optimal Strategy for Lynch Syndrome Identification? Byfield, Stacey A. DaCosta; Syngal, Sapna // American Journal of Gastroenterology;Nov2008, Vol. 103 Issue 11, p2837 

    Lynch syndrome, also known as hereditary non-polyposis colorectal cancer (HNPCC), is the most common form of inherited colorectal cancer (CRC). Affected individuals need to undergo intensive CRC surveillance, screening for associated cancers, and possibly prophylactic surgery. Clinically-based...

  • Announcements.  // American Journal of Gastroenterology;Dec1998, Vol. 93 Issue 12, p2648 

    Presents information on congresses and conventions on matters concerning on the subject of gastroenterology in 1999. 6th International Small Bowel Transplant Symposium; Gastroenterology Update 1999; 10th Annual Colorectal Disease in 1999: An International Exchange of Medical and Surgical Concepts.

  • Chemotherapy for colorectal cancer. Nicum, S.; Midgley, R.; Kerr, D.J. // Journal of the Royal Society of Medicine;Aug2000, Vol. 93 Issue 8, p416 

    The article discusses treatment options for colorectal cancer. Chemotherapeutic drugs available include 5-fluorouracil in combination with folinic acid and methotrexate, thymidylate synthase inhibitors, irinotecan and oxaliplatin. Adjuvant therapy is being given to patients who will undergo...

  • Invited Commentary. Gieseler, Frank // International Journal of Colorectal Disease;Mar2000, Vol. 15 Issue 2, p112 

    Presents a commentary about the dilemma of gastroenterological oncology. Emphasis on nonsteroidal anti-inflammatory drugs; Correlation between chronic inflammatory conditions of the bowel and the development of colon carcinoma; Indomethacin treatment of colon carcinoma cells.

  • The rationale behind complete mesocolic excision (CME) and a central vascular ligation for colon cancer in open and laparoscopic surgery. Søndenaa, K.; Quirke, P.; Hohenberger, W.; Sugihara, K.; Kobayashi, H.; Kessler, H.; Brown, G.; Tudyka, V.; D'Hoore, A.; Kennedy, R.; West, N.; Kim, S.; Heald, R.; Storli, K.; Nesbakken, A.; Moran, B. // International Journal of Colorectal Disease;Apr2014, Vol. 29 Issue 4, p419 

    Background: It has been evident for a while that the result after resection for colon cancer may not have been optimal. Several years ago, this was showed by some leading surgeons in the USA but a concept of improving results was not consistently pursued. Later, surgeons in Europe and Japan have...

  • Do young patients have different clinical presentation of colorectal cancer causing delay in diagnosis? Sousa, João; Souza, Caio; Fernandes, Maria; Castro Durães, Leonardo; Almeida, Romulo; Santos, Antônio; Silva, Eduardo; Oliveira, Paulo // International Journal of Colorectal Disease;Apr2014, Vol. 29 Issue 4, p519 

    Purpose: The incidence of colorectal cancer is increasing among young patients. In these patients, colorectal cancer is believed to have a poorer prognosis because it is more aggressive and diagnosed at later stages; however, the behavior of these tumors in young patients remains to be...

  • Observational cross-sectional study of compliance with the fast track protocol in elective surgery for colon cancer in Spain. Alcántara-Moral, Manuel; Serra-Aracil, X.; Gil-Egea, M.; Frasson, M.; Flor-Lorente, B.; Garcia-Granero, E. // International Journal of Colorectal Disease;Apr2014, Vol. 29 Issue 4, p477 

    Purpose: The purpose of this study was to establish the degree of compliance with the fast track (enhanced recovery) protocol in habitual clinical practice and to determine which measures are fundamental for achieving the results obtained by applying the entire protocol. Methods: Observational,...

  • Documented quality of care in certified colorectal cancer centers in Germany: German Cancer Society benchmarking report for 2013. Wesselmann, S.; Winter, A.; Ferencz, J.; Seufferlein, T.; Post, S. // International Journal of Colorectal Disease;Apr2014, Vol. 29 Issue 4, p511 

    Purpose: In order to improve the quality of treatment for cancer patients the German Cancer Society (Deutsche Krebsgesellschaft) implemented a certification system for oncological care institutions. The certified colorectal cancer centers present the structures, processes and results of their...

  • The Knowledge of Colorectal Cancer Symptoms and Risk Factors among 10,078 Screening Participants: Are High Risk Individuals More Knowledgeable? Wong, Martin C. S.; Hirai, Hoyee W.; Luk, Arthur K. C.; Lam, Thomas Y. T.; Ching, Jessica Y. L.; Griffiths, Sian M.; Chan, Francis K. L.; Sung, Joseph J. Y. // PLoS ONE;Apr2013, Vol. 8 Issue 4, p1 

    Objectives: We tested the a priori hypothesis that self-perceived and real presences of risks for colorectal cancer (CRC) are associated with better knowledge of the symptoms and risk factors for CRC, respectively. Methods: One territory-wide invitation for free CRC screening between 2008...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics